Chief Medical Officer (consulting), Quanterix Corp
BIOGRAPHY
APR 13, 2017 1:30 PM PDT
Ultra-sensitive single-molecule array (Simoa) technology to revolutionize CNS biomarkers
Presented at:
Molecular Diagnostics Virtual Event Series 2017
Speaker
Abstract
The presentation will describe the principles of the ultra-sensitive single-molecule array (Simoa) developed by Quanterix and the application of the Simoa technology to the development of a toolbox of CNS biomarkers. The presentation will include several case studies across CNS diseases, ranging from traumatic brain injury to Alzheimer's Disease
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
APR 13, 2017 1:30 PM PDT
Share
Ultra-sensitive single-molecule array (Simoa) technology to revolutionize CNS biomarkers
Presented at:
Molecular Diagnostics Virtual Event Series 2017
Loading Comments...